High glucose and insulin promote<i>O-</i>GlcNAc modification of proteins, including α-tubulin

American Journal of Physiology - Endocrinology and Metabolism - Tập 284 Số 2 - Trang E424-E434 - 2003
Jennie Walgren1,2, Timothy S. Vincent3, Kevin L. Schey1, Maria G. Buse4,2
1Departments of Pharmacology
2Division of Endocrinology, Diabetes and Medical Genetics, Department of Medicine, and
3Pathology, and
4Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina 29425

Tóm tắt

Increased flux through the hexosamine biosynthesis pathway has been implicated in the development of glucose-induced insulin resistance and may promote the modification of certain proteins with O-linked N-acetylglucosamine ( O-GlcNAc). L6 myotubes (a model of skeletal muscle) were incubated for 18 h in 5 or 25 mM glucose with or without 10 nM insulin. As assessed by immunoblotting with an O-GlcNAc-specific antibody, high glucose and/or insulin enhanced O-GlcNAcylation of numerous proteins, including the transcription factor Sp1, a known substrate for this modification. To identify novel proteins that may be O-GlcNAc modified in a glucose concentration/insulin-responsive manner, total cell membranes were separated by one- or two-dimensional gel electrophoresis. Selected O-GlcNAcylated proteins were identified by mass spectrometry (MS) analysis. MS sequencing of tryptic peptides identified member(s) of the heat shock protein 70 (HSP70) family and rat α-tubulin. Immunoprecipitation/immunoblot studies demonstrated several HSP70 isoforms and/or posttranslational modifications, some with selectively enhanced O-GlcNAcylation following exposure to high glucose plus insulin. In conclusion, in L6 myotubes, Sp1, membrane-associated HSP70, and α-tubulin are O-GlcNAcylated; the modification is markedly enhanced by sustained increased glucose flux.

Từ khóa


Tài liệu tham khảo

10.1074/jbc.271.46.28741

10.1152/ajpendo.00060.2002

10.1074/jbc.271.38.23197

10.1074/jbc.M010411200

10.1074/jbc.R000010200

10.1021/bi0027480

10.1006/abio.2001.5132

Considine RV, 2000, J Clin Endocrinol Metab, 85, 3551

10.1210/endo.140.3.6563

10.1074/jbc.271.25.14692

10.1128/MCB.15.10.5444

10.1073/pnas.97.22.12222

10.1074/jbc.M010785200

10.1042/bj3520267

10.1016/S0014-5793(99)00877-7

10.1016/S0014-5793(99)01700-7

10.1074/jbc.M204335200

10.1074/jbc.M010420200

10.1074/jbc.M003432200

Gulve EA, 1994, J Biol Chem, 269, 18366, 10.1016/S0021-9258(17)32316-5

10.1074/jbc.273.6.3611

10.1128/MCB.17.5.2550

10.1002/(SICI)1097-4644(19980101)68:1<50::AID-JCB5>3.0.CO;2-V

10.1074/jbc.273.29.18173

10.1146/annurev.biochem.66.1.315

10.1126/science.1068408

10.1074/jbc.272.8.4889

10.1172/JCI119390

10.2337/diabetes.51.7.2090

10.1074/jbc.M200310200

10.1042/bj3460483

10.1016/0092-8674(88)90015-3

10.1152/ajprenal.2000.279.4.F718

10.1128/MCB.13.10.6052

10.1074/jbc.270.43.25985

10.1172/JCI119875

10.1074/jbc.272.14.9308

10.1074/jbc.274.45.32015

10.2337/diabetes.48.3.658

10.1042/bj3600179

10.1074/jbc.272.14.9316

Marshall S, 1991, J Biol Chem, 266, 4706, 10.1016/S0021-9258(19)67706-9

10.1073/pnas.152346899

Mitsumoto Y, 1992, J Biol Chem, 267, 4957, 10.1016/S0021-9258(18)42923-7

10.1074/jbc.M105452200

Murata V, 1994, J Biol Chem, 269, 20674, 10.1016/S0021-9258(17)32046-X

10.2337/diabetes.49.6.981

10.1152/ajpendo.00438.2001

10.1074/jbc.C100645200

10.1146/annurev.biochem.69.1.277

10.1074/jbc.M007610200

10.2337/diabetes.48.8.1562

Rice KM, 1992, J Biol Chem, 267, 10160

10.1007/BF00422363

10.1128/MCB.17.11.6472

10.1016/S0960-9822(00)00767-3

10.2337/diacare.13.6.610

10.1074/jbc.271.25.15237

10.1016/S0166-2236(98)01392-7

10.1210/mend.16.5.0836

10.3109/02656738909140446

10.1007/PL00000837

10.1073/pnas.072072399

10.1126/science.1058714

10.1073/pnas.111099998

10.1016/S0026-0495(98)90058-0